Healthcare of Ontario Pension Plan Trust Fund Boosts Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 1.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,236 shares of the company’s stock after buying an additional 632 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned about 0.13% of Establishment Labs worth $1,525,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. Hood River Capital Management LLC purchased a new stake in shares of Establishment Labs during the second quarter worth $43,000. California State Teachers Retirement System raised its position in Establishment Labs by 14.5% in the 1st quarter. California State Teachers Retirement System now owns 17,096 shares of the company’s stock valued at $870,000 after purchasing an additional 2,167 shares in the last quarter. Nkcfo LLC purchased a new position in shares of Establishment Labs in the 2nd quarter valued at about $227,000. Kornitzer Capital Management Inc. KS grew its position in shares of Establishment Labs by 2.5% during the third quarter. Kornitzer Capital Management Inc. KS now owns 248,435 shares of the company’s stock worth $10,750,000 after buying an additional 6,050 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Establishment Labs during the second quarter worth approximately $303,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Price Performance

Shares of NASDAQ:ESTA opened at $45.89 on Monday. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 12 month low of $22.05 and a 12 month high of $60.12. The firm has a market capitalization of $1.28 billion, a P/E ratio of -17.79 and a beta of 1.20. The company’s fifty day moving average price is $43.20 and its 200 day moving average price is $44.72.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Stephens reiterated an “overweight” rating and set a $68.00 price target on shares of Establishment Labs in a report on Wednesday, August 7th. Citigroup boosted their target price on shares of Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. JPMorgan Chase & Co. cut their price target on Establishment Labs from $61.00 to $50.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. Finally, BTIG Research upped their price objective on Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $60.60.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.